http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-063022-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| filingDate | 2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-063022-A1 |
| titleOfInvention | INDOL DERIVATIVES ANTAGONISTS OF THE GLUCAGON RECEIVER, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES TO TREAT MELLITUS TYPE 2 DIABETES AND RELATED PATHOLOGICAL STATES. |
| abstract | Claim 1: A compound represented by formula (1) or a pharmaceutically acceptable salt or solvate thereof, wherein: ring A represents a phenyl or naphthyl group; each R1 and R2 represents H or is selected from the group consisting of halo, CN, OH, NO2, CO2Ra, NRaRb, S (O) pRa, C1-10 alkyl, C2-10 alkenyl or C1-10 alkoxy, the alkyl portions being and C1-10 alkyl alkenyl, C2-10 alkenyl and C1-10 alkoxy optionally substituted with 1-5 halo atoms, until perhalo; and also optionally substituted with a group selected from OH, oxo and C1-6 alkoxy; p represents 0, 1 or 2; each Ra and Rb independently represents H or C1-4 alkyl optionally substituted with 1-5 halo atoms until perhalo; and also optionally substituted with 1 group selected from OH, oxo, and C1-6 alkoxy; R3 represents C1-6 alkyl or X-C2-6 alkenyl, each optionally substituted with 1-5 halo atoms to perhalo and, in addition optionally substituted with 1 group selected from OH, oxo, and C1-6 alkoxy and R4 represents H or C1-4 alkyl optionally substituted with 1-3 halo atoms to perhalo and 1 phenyl ring. |
| priorityDate | 2006-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.